Literature DB >> 10339484

Noninflammatory expression of E-selectin is regulated by cell growth.

J Luo1, G Paranya, J Bischoff.   

Abstract

E-selectin, an endothelial-specific adhesion molecule best known for its role in leukocyte adhesion, is not detected in quiescent endothelial cells, but is induced by inflammatory stimuli. However, E-selectin is also expressed in proliferating endothelial cells under noninflammatory conditions in vivo and in vitro, suggesting that E-selectin is also regulated by growth signals. To investigate E-selectin expression in lipopolysaccharide-stimulated versus nonstimulated proliferating cells, we analyzed the distribution of E-selectin-positive human microvascular endothelial cells in G0/G1, S, and G2/M phases of the cell cycle under both conditions. Lipopolysaccharide treatment resulted in uniformly increased E-selectin expression in cells in G0/G1, S, and G2/M. In contrast, levels of E-selectin in nonstimulated proliferating cells showed a linear correlation with the percentage of cells in G2/M. E-selectin in proliferating endothelial cells was not reduced by addition of soluble tumor necrosis factor-alpha-receptor or soluble interleukin-1-receptor indicating that its expression was not due to endogenous production of either cytokine. In addition, E-selectin was increased in cells stimulated with basic fibroblast growth factor, a well-known mitogen for endothelial cells. E-selectin in proliferating endothelial cells is functional, as shown by E-selectin-dependent adhesion of the promyelocytic leukemia cell line HL-60 to subconfluent human microvascular endothelial cells. In summary, these studies indicate that E-selectin can be regulated by a non-inflammatory pathway that is related to the proliferative state of the endothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339484

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

Review 2.  Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.

Authors:  Raquel Yokoda; Bolni M Nagalo; Brent Vernon; Rahmi Oklu; Hassan Albadawi; Thomas T DeLeon; Yumei Zhou; Jan B Egan; Dan G Duda; Mitesh J Borad
Journal:  Oncolytic Virother       Date:  2017-11-08

3.  Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction.

Authors:  James R Wodicka; Andrea M Chambers; Gurneet S Sangha; Craig J Goergen; Alyssa Panitch
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-29

4.  Role of Galectin-9 in Atopic Dermatitis - Is It Mediated Through E Selectin? A Clinical and Immunohistochemical Study.

Authors:  Azza Gaber Antar Farag; Dalia Rifaat Al-Sharaky; Sawsan Samy Allam; Hesham Nabil Khaled
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-01-10

5.  Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates.

Authors:  Nicole M Cordina; Nima Sayyadi; Lindsay M Parker; Arun Everest-Dass; Louise J Brown; Nicolle H Packer
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

6.  Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.

Authors:  Hideaki Nishihara; Benjamin D Gastfriend; Sasha Soldati; Sylvain Perriot; Amandine Mathias; Yasuteru Sano; Fumitaka Shimizu; Fabien Gosselet; Takashi Kanda; Sean P Palecek; Renaud Du Pasquier; Eric V Shusta; Britta Engelhardt
Journal:  FASEB J       Date:  2020-10-30       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.